albert esquirol

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (17)

Collaborators (12)

Miguel Arguello-Tomas

Josep Carreras Leukaemia Research Institute

Sara Villar

Clinica Universidad de Navarra

Ana Isabel Benito Bernal

Profesor universidad privada (acreditación ANECA)

Universidad Internacional de La Rioja

Eliane Gluckman

José Manuel Soria Fernández

Principal Investigator. Head of Group

Hospital de la Santa Creu i Sant Pau

ANA CAROLINA CABALLERO GONZÁLEZ

Josep Carreras Leukaemia Research Institute

Carmen Álvarez Fernández

Institut de Recerca Sant Pau

Javier Briones Meijide

University of Barcelona

Lucia Lopez Corral

Universidad de Salamanca

Isabel Badell

University of Barcelona

Silvana Novelli

Isabel Regalado-Artamendi

Instituto de Investigación Sanitaria Gregorio Marañón

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

albert esquirol

Research Interests

Explore related searches

Contact this professor

Articles (17)

Collaborators (12)

Miguel Arguello-Tomas

Sara Villar

Ana Isabel Benito Bernal

Eliane Gluckman

José Manuel Soria Fernández

ANA CAROLINA CABALLERO GONZÁLEZ

Carmen Álvarez Fernández

Javier Briones Meijide

Lucia Lopez Corral

Isabel Badell

Silvana Novelli

Isabel Regalado-Artamendi

Make your next move.

albert esquirol

Research Interests

Explore related searches

Contact this professor

Articles (17)

HSP-CAR30 WITH A HIGH PROPORTION OF LESS-DIFFERENTIATED T CELLS PROMOTES DURABLE RESPONSES IN REFRACTORY CD30+ LYMPHOMA

Severity and organ distribution of graft‐versus‐host disease with post‐transplant cyclophosphamide versus calcineurin inhibitor plus methotrexate/mycophenolate mofetil or sirolimus in allogenic HLA‐matched or single‐allele mismatched stem cell transplantation

Cardiac events after allo-HCT in patients with acute myeloid leukemia.

Cardiac events occurring after allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide. Study conducted on behalf of the GETH-TC.

Development and Clinical Validation of Liquid Chromatography-Tandem Mass Spectrometry for Measuring Ruxolitinib in Steroid-Refractory Graft-Versus-Host Disease: A First Step Towards Optimized Treatment.

Comparison of Three Graft-versus-Host Disease Prophylaxis Strategies after T Cell-Replete Haploidentical Hematopoietic Transplantation: Tacrolimus versus Calcineurin Inhibitors + Mycophenolate Mofetil versus Sirolimus + Mycophenolate Mofetil

Sequence matters: Total body irradiation (TBI)‐based myeloablative conditioning with post‐transplant cyclophosphamide may reduce the early nonrelapse mortality compared with pretransplant cyclophosphamide plus <scp>TBI</scp>

Age, CD34+ cell dose, conditioning and pre‐transplant cytopenias can help predict transfusion support in lymphoma patients undergoing autologous stem cell transplantation

Outcomes of subsequent neoplasms after umbilical cord blood transplantation in Europe

Outcome improvement over time in reduced intensity conditioning hematopoietic transplantation: a 20-year experience.

Post thawing viable CD34+ Cells dose is a better predictor of clinical outcome in lymphoma patients undergoing autologous stem cell transplantation

Daratumumab may be the most effective treatment for post-engraftment pure red cell aplasia due to persistent anti-donor isohemagglutinins after major ABO-mismatched allogeneic transplantation

Defibrotide in hematopoietic stem cell transplantation: A multicenter survey study of the Spanish Hematopoietic Stem Cell Transplantation Group (GETH)

Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide

COMBINING THREE DIFFERENT PRE-TRANSPLANT SCORES IMPROVES PREDICTIVE VALUE IN PATIENTS AFTER HAPLOIDENTICAL STEM CELL TRANSPLANTATION WITH TBF CONDITIONING AND PTCY.

Addition of plerixafor to G-CSF in poor mobilizing healthy related donors overcame mobilization failure: An observational case series on behalf of the Grupo Español de Trasplante Hematopoyético (GETH).

Cytomegalovirus DNAemia and risk of mortality in allogeneic hematopoietic stem cell transplantation: Analysis from the Spanish Hematopoietic Transplantation and Cell Therapy Group.

Collaborators (12)

Miguel Arguello-Tomas

Sara Villar

Ana Isabel Benito Bernal

Eliane Gluckman

José Manuel Soria Fernández

ANA CAROLINA CABALLERO GONZÁLEZ

Carmen Álvarez Fernández

Javier Briones Meijide

Lucia Lopez Corral

Isabel Badell

Silvana Novelli

Isabel Regalado-Artamendi

Make your next move.